Michelle Abou-Jaoude is an Ophthalmology physician affiliated with University of Kentucky. OpenAlex indexes 14 publications with 325 citations (h-index 5); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Perimeter Dr Ste 200
Lexington, KY 405174121
Telephone
859-278-9393Provider last certified this registry record 18 Oct 2021.
Clinical trials
2 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- Carl Zeiss Meditec USA, Inc.Program year20241 payment
- Carl Zeiss Meditec USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
95.7%Antineovascularisation agents92.3%Faricimab-svoa100%Part B, office-administered≥16 patientsCorticosteroid1.1%Prednisolone Acetate100%Part D≥29 patients+ 4 more classes in this area
Cancer & immunology
3.7%Vascular Endothelial Growth Factor Inhibitor3.7%Aflibercept100%Part B, office-administered≥21 patientsCardiovascular
0.4%Beta blocker0.4%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tractional Retinal Detachment in a Patient With a History of Methamphetamine Use
Journal of VitreoRetinal Diseases
2025 - Accuracy of Ophthalmology Clinic Follow-Up in the Incarcerated Patient Population
Journal of Academic Ophthalmology
2022 - Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab
International Journal of Retina and Vitreous
2022
Similar KOLs
Other experts from the same institution or the same specialty.
David Moliterno, MD
University of Kentucky
Robert Dipaola
University of Kentucky
Darwin Conwell, MD
University of Kentucky
Phillip Tibbs
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”